Physicians Office Resource - August 2019

Physicians office Resource 2019 Issue 8

™

Resources for You, Your Patients, & Your Practice

NAIL IT WITH ONE SWAB

The BioFire® FilmArray® Respiratory Panel EZ (RP EZ) Page 4

CLIA WAIVED

also in this issue Group A Strep Testing Guidelines and Limitations Page 6 Melecular Lateral Flow Diagnostics: A New Era in Point-of-Care Page 22 MDescapes: Luxurious Getaways and Special Offers Exclusively for Physicians Page 25 Give Your Practice the Recognition it Deserves – Advertise Page 36

2019 Issue 8.indd 1

8/16/19 12:56 PM

2019 Issue 8

Physicians office Resource™

PHYSICIANS office RESOURCE

Resources for You, Your Patients, & Your Practice Published by Medical Education Resources, LLC Publisher Aaron R. Medaris amedaris@physiciansofficeresource.com CEO Andrew C. Nimmo acnimmo@physiciansofficeresource.com President John D. Pasquale jpasquale@pharmaconnect.com Business Manager Marci J. Hills mhills@physiciansofficeresource.com

GETTING THE MOST FROM THIS GUIDE There are two simple ways to request information about the products and services found in Physicians Office Resource.

A B

Go to www.PhysiciansOfficeResource.com and enter the four-digit reference number found next to the product or service into the search field, then request additional information, schedule a demo, or speak with a sales agent all with just a simple click of a button.

2

Find the Business Reply Card in this issue, circle the desired reference numbers, complete the form, and drop into any USPS mailbox. A representative will contact you as quickly as possible to answer your questions.

www.PhysiciansOfficeResource.com

2019 Issue 8.indd 2

Travel Editor Brandi L. Brower Editorial Board Michael Paquin, FHIMSS Barry Craig, MLT (NCA), CLC Staff Writer Dylan J. Chadwick Creative Director Production Manager Keith A. Katsikas Jr Copyright ©2019

To continue your free subscription of Physicians Office Resource magazine, please fill out the Business Reply Card (BRC) located within this magazine and drop in any United States Post Office mailbox.

If you are a manufacturer of medical products or provide services to medical professionals and would like to advertise your products or services to the nation’s top physicians doing in-office testing, call 801-380-6094 or visit: POR.io for more information.

Thank you!

8/16/19 12:56 PM

NEW

TURN SMALL PLACES INTO SMART SPACES With reduced budgets, shrinking laboratory space and staffing challenges, many laboratories need a solution that lets them work smarter with less.

The CELL-DYN Emerald 22 AL is a full performance, automated, optical 5-part differential analyzer that delivers smarter results for small to mid-size clinical laboratories with: • Compact design maximizes valuable laboratory space • Ease of use and walkaway functionality optimizes staff time • Smart open tube sample device ensures user safety

41 cm

Visit www.corelaboratory.abbott/hematology to learn how the new CELL-DYN Emerald 22 AL can help your laboratory operate more efficiently.

50 cm

CH OOSE TRA NSF O RMATION

TM

Achieve measurably better healthcare performance.

6700

CELL-DYN Emerald 22 AL is a Class 1 laser. For in vitro diagnostic only.

Refer to the Operator’s Manual for operational precautions, limitations, and hazards.

CELL-DYN Emerald and CHOOSE TRANSFORMATION are trademarks of Abbott Laboratories in various jurisdictions.

CAUTION: United States Federal law restricts this device to sale and distribution by or on the order of a physician, or to a clinical laboratory. © 2019 Abbott Laboratories. ADD-00064842.

2019 Issue 8.indd 3

8/16/19 12:56 PM

2019 Issue 8

PHYSICIANS office RESOURCE

Physicians office Resource ™

CLIA WAIVED 6701

table of contents

MDescapes Luxurious Getaways & Exclusive Deals for POR Magazine Readers

25

articles in this issue

Nail it with One Swab The BioFire® FilmArray® Respiratory Panel EZ (RP EZ) uses a molecular syndromic approach to accurately detect and identify a wide range of pathogens—not just Flu A and B. As a healthcare provider, this means your patients can receive the right treatment the first time, potentially leading to higher patient satisfaction and lower costs. And as the name implies, it’s easy and can be performed right in your office or clinic. 6701

Back to School... Back to FLU It’s that time of year again. Luckily, there are some great products available to help you accurately diagnosis your patients this flu season. CLIA waived, molecular, immunoassay, and more. To view what products are available and which one is best for your practice take a look at pages 8-9 in this issue.

4 2019 Issue 8.indd 4

Group A Strep Testing Guidelines, Limitations Strep tests are used to determine if a person with a sore throat (pharyngitis) has strep throat, an infection of the throat and tonsils caused bythe bacteria Streptococcus...

Melecular Lateral Flow Diagnostics: A New...

6

22

If you’re like many physicians and Point of Care (POC) laboratories, you may be dealing with suboptimal performance from some of your current diagnostic...

Give Your Practice the Reputation It Deserves

36

To attract new patients, you have to get the word out about your practice. You can do this through conducting a marketing campaign or by...

8/16/19 12:56 PM

Systems for Clinical Laboratories, Large and Small CHEMISTRY

IMMUNOASSAY

HEMATOLOGY

SMALL PRACTICES / BENCHTOP

6702

Chemistry: Up to 240 photometric tests/hr; 400 tests/hr with ISE

6703

6704

BC-3600 Immunoassay: Up to 36 tests/hr

Hematology: Up to 60 samples/hr 3-Part Diff

MIDSIZE GROUP PRACTICES 6705

6706

6707

BC-5390 Chemistry: Up to 400 photometric tests/hr; 800 tests/hr with ISE

With 9-Tray Sorter Immunoassay: Up to 90 tests/hr

Hematology: Up to 60 samples/hr 5-Part Diff

LARGE GROUP PRACTICES AND SMALL HOSPITALS 6708

6709

6710

BC-5390 Chemistry: Up to 900 photometric tests/hr; 1,200 tests/hr with ISE

With 19-Tray Sorter Immunoassay: Up to 90 tests/hr

Hematology: Up to 60 samples/hr 5-Part Diff

www.carolinachemistries.com contactsales@carolinachemistries.com

877-722-8910 888-442-8303 POR_back_cover_ad.00 JUN 2019

2019 Issue 8.indd 5

8/16/19 12:56 PM

2019 Issue 8

PHYSICIANS office RESOURCE

GROUP A STREP TESTING GUIDELINES AND LIMITATIONS Irwin Z. Rothenberg, MBA, MS, CLS(ASCP) Technical Writer /Quality Advisor, COLA Resources, Inc.

Strep tests are used to determine if a person with a sore throat (pharyngitis) has strep throat, an infection of the throat and tonsils caused by the bacteria Streptococcus pyogenes, also called Group A Streptococcus (GAS), or if the sore throat is caused by a virus. The majority of sore throats (70%-85%) are actually viral in nature, and will resolve without treatment within a few days.

However, it is important to determine when sore throats are caused by GAS, since this is the most common bacterial cause of acute pharyngitis, responsible for 5%–15% of sore throat visits in adults and 20%–30% in children. It is most common in children ages 5 to 15 years old (over 50 % of the cases occur within this age bracket); it is very contagious; and needs to be identified as soon as possible, and treated with antibiotics.

Accurate diagnosis of streptococcal pharyngitis followed by appropriate antimicrobial therapy is important for the prevention of acute rheumatic fever; for the prevention of suppurative complications (e.g. peritonsillar abscess, cervical lymphadenitis, mastoiditis, and, possibly, other invasive infections); to improve clinical symptoms and signs; for the rapid decrease in contagiousness; for the reduction in transmission of GAS to family members, classmates, and other close contacts of the patient; to allow for the rapid resumption of usual activities; and for the minimization of potential adverse effects of inappropriate antimicrobial therapy.

6

Fortunately, most streptococcal infections are now routinely diagnosed and treated through rapid strep testing, these complications are rare in the United States, but they do still occur.

Establishing the Diagnosis of GAS Pharyngitis 1. Swabbing the throat and testing for GAS pharyngitis by rapid strep test and/or throat culture should be performed because clinical features alone do not reliably discriminate between GAS and viral pharyngitis except when overt viral features like runny nose, cough, oral ulceration, and/ or hoarseness are present. In children and adolescents, negative rapid strep tests should be backed up by a throat culture; however, positive rapid strep tests do not necessitate a back-up culture because they are highly specific.

2. The routine use of back-up throat cultures for those with a negative rapid strep test is not generally recommended for adults, because of the low incidence of GAS pharyngitis, and because the risk of subsequent acute rheumatic fever is exceptionally low. Physicians who wish to ensure they are achieving maximal sensitivity in diagnosis may (of course) continue to use conventional throat culture or back up negative rapid strep tests with a culture.

3. Anti-streptococcal antibody titers are not recommended in the routine diagnosis of acute pharyngitis as they reflect past but not current events.

www.PhysiciansOfficeResource.com

2019 Issue 8.indd 6

8/16/19 12:56 PM

Who Should Undergo Testing for GAS Pharyngitis?

1. Testing for GAS pharyngitis usually is not recommended for children or adults with acute pharyngitis with clinical and epidemiological features that strongly suggest a viral basis (e.g, cough, runny nose, hoarseness, and oral ulceration).

Unfortunately, the sensitivity of most of these tests is 70%–90%, compared with blood agar plate culture.

The first RSTs used latex agglutination methods, were relatively insensitive, and had unclear end points. Newer tests based on enzyme immunoassay “Physicians who wish to techniques ensure they are achieving offer increased maximal sensitivity sensitivity and a more sharply in diagnosis may (of defined end point. course) continue to use

2. Diagnostic studies for GAS pharyngitis are not indicated conventional throat culture for children under three years The practitioner old because acute rheumatic should be aware or back up negative rapid fever is rare in children under that some of strep tests with a culture.” three years old, and the these rapid Irwin Z. Rothenberg incidence of streptococcal strep tests are pharyngitis and the classic not waived, and presentation of streptococcal pharyngitis are uncommon therefore, require proper certification or accreditation of in this age group. Selected children under three years old the physician’s laboratory. Neither conventional throat who have other risk factors, such as an older sibling with culture nor RSTs accurately differentiate acutely infected GAS infection, may be considered for testing persons from asymptomatic streptococcal carriers with viral pharyngitis. Nevertheless, they allow physicians to withhold 3. Follow-up post treatment throat cultures or rapid antibiotics from the great majority of patients with sore strep testing are not recommended routinely but may be throats for whom results of culture or RST are negative. considered in special circumstances This is of extreme importance, because nationally up to 70% of patients with sore throats seen in primary care settings 4. Diagnostic testing or empiric treatment of receive prescriptions for antimicrobials, while only 20%–30% asymptomatic household contacts of patients with acute are likely to have GAS pharyngitis. streptococcal pharyngitis is not routinely recommended If the results of the rapid strep test are positive, further testing is not necessary, and treatment can be started immediately.

Testing Guidelines l. The Rapid Strep Test (RST) Description A major disadvantage of throat cultures is the delay (overnight or longer) in obtaining results. RSTs have been developed for the identification of GAS pharyngitis directly from throat swabs, with shorter turnaround time. Rapid identification and treatment of patients with GAS pharyngitis can reduce the risk of spread, allowing the patient to return to school or work sooner, and can reduce the acute associated morbidity. The use of RSTs for certain populations (e.g, patients in emergency departments) was reported to significantly increase the number of patients appropriately treated for streptococcal pharyngitis, compared with traditional throat cultures.

RSTs currently available are highly specific (approximately 95%) when compared with blood agar plate cultures. False-positive test results are highly unusual, and therefore therapeutic decisions can be made with confidence on the basis of a positive test result.

Since the sensitivities of the various RSTs are <90% in most studied populations of children and adolescents, and because the proportion of acute pharyngitis due to GAS in children and adolescents is sufficiently high (20%–30%), a negative RADT should be accompanied by a follow-up or back-up throat culture in children and adolescents, while this is not necessary in adults under usual circumstances, as noted above.

Procedure Obtaining a specimen is the same whether your doctor will do a throat culture or rapid test for strep. A cotton swab (similar to a Q-tip) is quickly rubbed over both tonsils as well as the back wall of the mouth (the posterior pharynx). It is important to avoid contact with other structures inside the mouth such as the tongue or cheeks. The swab is then placed in a specialized container and the rapid test performed. Many people find that obtaining the swab produces a gagging sensation. However, since the entire swabbing process lasts less than five seconds this inconvenience is minimal.

Limitations 1. There are several manufactures of rapid strep tests.

Each manufacturer has designed their test to respond...

Read this and other articles at www.PhysiciansOfficeNews.com

2019 Issue 8.indd 7

7

8/16/19 12:56 PM

6711

CLIA-WAIVED BIOFIRE® FILMARRAY® RESPIRATORY PANEL (RP) EZ

PHYSICIANS office RESOURCE

2019 Issue 8

FOCUSONFLU

From BioFire

The BioFire RP EZ accurately detects and identifies 14 viral and bacterial pathogens—not just Flu A and Flu B— so you can provide your patients with the right treatment, the first time. The test is easy and can be performed right in your office or clinic, with results in about an hour. The BioFire RP EZ is designed to run on a single computer/ instrument configuration (EZ Configuration) of the BioFire® FilmArray® 2.0 System.

View Brochures, Videos & Mores at POR.io Enter Number 6711 in the Search Area

BIOFIRE® FILMARRAY® TORCH

6712

From BioFire

The BioFire® FilmArray® Torch is a fully integrated, random, and continuous access system designed to meet your laboratory’s syndromic infectious disease testing needs. The BioFire Torch offers a radically reduced benchtop footprint, saving precious space in the lab, and its scalability meets high throughput demands. BioFire® FilmArray® Link Software automatically uploads patient results. Fully compatible with all CLIA Moderate BioFire® FilmArray® Panels, the BioFire Torch helps you maximize efficiency and productivity.

View Brochures, Videos & Mores at POR.io Enter Number 6712 in the Search Area

CLIA-WAIVED FOR RAPID DETECTION OF FLU A+B 6713

From BD Veritor

The CLIA-Waved BD Veritor™ Plus System for rapid detection of Flu A+B, combines speed and accuracy. It provides clear digital results in under 11 minutes and has demonstrated performance compared to molecular tests.[1] It is easy to use and has a low cost of ownership. The BD Veritor ™ Plus System is CLIA-Waved for Flu, RSV and Group A Strep.

[1] (BD Veritor System for Rapid Detection of Flu A+B, CLIA-waved kit package insert, 8087667 (14) 2018-06. BD Veritor System for Rapid Detection of Flu A+B, laboratory kit package insert, 8087666 (11) 2017-10., 2018-06.)

View Brochures, Videos & Mores at POR.io Enter Number 6713 in the Search Area 8

www.PhysiciansOfficeResource.com

2019 Issue 8.indd 8

8/16/19 12:56 PM

FOCUSONFLU 6714

ACUCY INFLUENZA A&B TEST From Sekisui

The Acucy™ Influenza A&B Test is for the rapid, qualitative detection of influenza A and B viral nucleoprotein antigens from both nasal and nasopharyngeal swabs. Utilizing the Acucy™ Reader in either the point-of-care or laboratory setting, workflow flexibility is achieved with both Read Now and Walk Away features. The combination provides clinicians with standardized and definitive result interpretation.

View Brochures, Videos & Mores at POR.io Enter Number 6714 in the Search Area

RELIABLE DETECTION OF STREP A, FLU A, FLU B AND RSV

6715

From Cepheid

Cepheid’s GeneXpert Xpress® brings standardized molecular testing to any healthcare setting. Employing the highly accurate and easy to use lab in a cartridge technology in every GeneXpert system, the GeneXpert Xpress® is a true on-demand walkaway testing system that provides accurate and reliable detection of Strep A, Flu A, Flu B and RSV. Two or four-module configurations save valuable bench space and reduce the need for multiple testing platforms.

View Brochures, Videos & Mores at POR.io Enter Number 6715 in the Search Area

SILARIS™ INFLUENZA A&B TEST 6716

From Sekisui Diagnostics

A molecular test utilizing polymerase chain reaction (PCR) technology providing accurate results for early diagnosis and proper management of influenza.

Accurate √ Molecular Results √ State-of-the art microfluidic cassette technology √ PCR test using proprietary OscAR™ Technology Affordable √ Single Test Diagnosis √ Controls in every kit √ Molecular reimbursement (CPT Code 87502) Simple √ Easy to Use √ Compact portable dock with no calibration required √ Room temperature storage

View Brochures, Videos & Mores at POR.io Enter Number 6716 in the Search Area www.PhysiciansOfficeNews.com 9 2019 Issue 8.indd 9

8/16/19 12:56 PM

Jacobâ&#x20AC;&#x2122;s birthday party No, my migraine wants me to lie down in the dark Yes, I will attend

Š 2019 Teva Pharmaceuticals USA, Inc.

2019 Issue 8.indd 10

FRE-41678

March 2019

8/16/19 12:56 PM

Less migraine.

More moments.

TM

Help patients say yes to more moments AJOVY® (fremanezumab-vfrm) injection is the only anti-CGRP treatment for the prevention of migraine with quarterly and monthly dosing options1 More migraine-free days with AJOVY in clinical trials1

INDICATION

AJOVY is indicated for the preventive treatment of migraine in adults.

IMPORTANT SAFETY INFORMATION

Contraindications: AJOVY is contraindicated in patients with serious hypersensitivity to fremanezumab-vfrm or to any of the excipients.

Hypersensitivity Reactions: Hypersensitivity reactions, including rash, pruritus, drug hypersensitivity, and urticaria were reported with AJOVY in clinical trials.

Most reactions were mild to moderate, but some led to discontinuation or required corticosteroid treatment.

Most reactions were reported from within hours to one month after administration. If a hypersensitivity reaction occurs, consider discontinuing AJOVY and institute appropriate therapy.

Adverse Reactions: The most common adverse reactions (≥5% and greater than placebo) were injection site reactions.

Please see Brief Summary of full Prescribing Information on the following page.

To learn more, visit AJOVYhcp.com CGRP: calcitonin gene-related peptide.

Reference: 1. AJOVY® (fremanezumab-vfrm) injection Current Prescribing Information. North Wales, PA: Teva Pharmaceuticals USA, Inc.

2019 Issue 8.indd 11

8/16/19 12:56 PM

BRIEF SUMMARY OF PRESCRIBING INFORMATION FOR AJOVY® (fremanezumab-vfrm) injection, for subcutaneous use SEE PACKAGE INSERT FOR FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE AJOVY is indicated for the preventive treatment of migraine in adults.

2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosage Two subcutaneous dosing options of AJOVY are available to administer the recommended dosage: • 225 mg monthly, or • 675 mg every 3 months (quarterly), which is administered as three consecutive subcutaneous injections of 225 mg each.

When switching dosage options, administer the first dose of the new regimen on the next scheduled date of administration. If a dose of AJOVY is missed, administer as soon as possible. Thereafter, AJOVY can be scheduled from the date of the last dose.

2.2 Important Administration Instructions AJOVY is for subcutaneous use only.

AJOVY may be administered by healthcare professionals, patients, and/or caregivers. Prior to use, provide proper training to patients and/or caregivers on the preparation and administration of AJOVY prefilled syringe, including aseptic technique [see Instructions for Use in full Prescribing Information]: • Remove AJOVY from the refrigerator. Prior to use, allow AJOVY to sit at room temperature for 30 minutes protected from direct sunlight. Do not warm by using a heat source such as hot water or a microwave. Do not use AJOVY if it has been at room temperature for 24 hours or longer.

• Follow aseptic injection technique every time AJOVY is administered.

• Inspect AJOVY for particles or discoloration prior to administration. Do not use if the solution is cloudy, discolored, or contains particles.

• Administer AJOVY by subcutaneous injection into areas of the abdomen, thigh, or upper arm that are not tender, bruised, red, or indurated. For multiple injections, you may use the same body site, but not the exact location of the previous injection.

• Do not co-administer AJOVY with other injectable drugs at the same injection site.

4 CONTRAINDICATIONS AJOVY is contraindicated in patients with serious hypersensitivity to fremanezumabvfrm or to any of the excipients [see Warnings and Precautions (5.1)].

5 WARNINGS AND PRECAUTIONS 5.1 Hypersensitivity Reactions Hypersensitivity reactions, including rash, pruritus, drug hypersensitivity, and urticaria, were reported with AJOVY in clinical trials. Most reactions were mild to moderate, but some led to discontinuation or required corticosteroid treatment. Most reactions were reported from within hours to one month after administration.

If a hypersensitivity reaction occurs, consider discontinuing AJOVY, and institute appropriate therapy.

6 ADVERSE REACTIONS The following clinically significant adverse reactions are discussed in greater detail in other sections of the labeling: • Hypersensitivity Reactions [see Warnings and Precautions (5.1)] 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug, and may not reflect the rates observed in clinical practice.

The safety of AJOVY was evaluated in 2512 patients with migraine who received at least 1 dose of AJOVY, representing 1279 patient-years of exposure. Of these, 1730 patients were exposed to AJOVY 225 mg monthly or AJOVY 675 mg quarterly for at least 6 months, 775 patients for at least 12 months, and 138 patients for at least 15 months. In placebo-controlled clinical trials (Studies 1 and 2), 662 patients received AJOVY 225 mg monthly for 12 weeks (with or without a loading dose of 675 mg), and 663 patients received AJOVY 675 mg quarterly for 12 weeks. In the controlled trials, 87% of patients were female, 80% were White, and the mean age was 41 years.

The most common adverse reactions in the clinical trials for the preventive treatment of migraine (incidence at least 5% and greater than placebo) were injection site reactions. The adverse reactions that most commonly led to discontinuations were injection site reactions (1%). Table 1 summarizes adverse reactions reported in the 3-month placebo-controlled studies (Study 1 and Study 2), and the 1-month follow-up period after those studies.

Table 1: Adverse Reactions Occurring with an Incidence of At Least 2% for Either Dosing Regimen of AJOVY and At Least 2% Greater Than Placebo in Studies 1 and 2 Placebo AJOVY AJOVY Monthly 225 mg Monthly 675 mg Quarterly (n= 668) (n= 667) (n= 290) % % % Injection site reactionsa 43 45 38 a Injection site reactions include multiple related adverse event terms, such as injection site pain, induration, and erythema.

Adverse Reaction

2019 Issue 8.indd 12

AJOVY® (fremanezumab-vfrm) injection 6.2 Immunogenicity As with all therapeutic proteins, there is a potential for immunogenicity. The detection of antibody formation is highly dependent on sensitivity and specificity of the assay. Additionally, the observed incidence of antibody (including neutralizing antibody) positivity in an assay may be influenced by several factors, including assay methodology, sample handling, timing of sample collection, concomitant medications, and underlying disease. For these reasons, comparison of the incidence of antibodies to fremanezumab-vfrm in the studies described below with the incidence of antibodies in other studies to other products may be misleading. Clinical immunogenicity of AJOVY was monitored by analyzing anti-drug antibodies (ADA) and neutralizing antibodies in drug-treated patients.

The data reflect the percentage of patients whose test results were positive for antibodies to AJOVY in specific assays.

In 3-month placebo-controlled studies, treatment-emergent ADA responses were observed in 6 out of 1701 (0.4%) AJOVY-treated patients. One of the 6 patients developed anti-AJOVY neutralizing antibodies at Day 84. In the ongoing long-term open-label study, ADA were detected in 1.6% of patients (30 out of 1888). Out of 30 ADA-positive patients, 17 had a neutralizing activity in their post-dose samples. Although these data do not demonstrate an impact of antifremanezumab-vfrm antibody development on the efficacy or safety of AJOVY in these patients, the available data are too limited to make definitive conclusions.

8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy Risk Summary There are no adequate data on the developmental risk associated with the use of AJOVY in pregnant women. AJOVY has a long half-life. This should be taken into consideration for women who are pregnant or plan to become pregnant while using AJOVY. Administration of fremanezumab-vfrm to rats and rabbits during the period of organogenesis or to rats throughout pregnancy and lactation at doses resulting in plasma levels greater than those expected clinically did not result in adverse effects on development [see Animal Data].

In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. The estimated rate of major birth defects (2.2-2.9%) and miscarriage (17%) among deliveries to women with migraine are similar to rates reported in women without migraine.

Clinical Considerations Disease-Associated Maternal and/or Embryo/Fetal Risk Published data have suggested that women with migraine may be at increased risk of preeclampsia during pregnancy.

Data Animal Data When fremanezumab-vfrm (0, 50, 100, or 200 mg/kg) was administered to male and female rats by weekly subcutaneous injection prior to and during mating and continuing in females throughout organogenesis, no adverse embryofetal effects were observed. The highest dose tested was associated with plasma exposures (AUC) approximately 2 times that in humans at a dose of 675 mg.

Administration of fremanezumab-vfrm (0, 10, 50, or 100 mg/kg) weekly by subcutaneous injection to pregnant rabbits throughout the period of organogenesis produced no adverse effects on embryofetal development. The highest dose tested was associated with plasma AUC approximately 3 times that in humans (675 mg).

Administration of fremanezumab-vfrm (0, 50, 100, or 200 mg/kg) weekly by subcutaneous injection to female rats throughout pregnancy and lactation resulted in no adverse effects on pre- and postnatal development. The highest dose tested was associated with plasma AUC approximately 2 times that in humans (675 mg).

8.2 Lactation Risk Summary There are no data on the presence of fremanezumab-vfrm in human milk, the effects on the breastfed infant, or the effects on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for AJOVY and any potential adverse effects on the breastfed infant from AJOVY or from the underlying maternal condition.

8.4 Pediatric Use Safety and effectiveness in pediatric patients have not been established.

8.5 Geriatric Use Clinical studies of AJOVY did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.

Manufactured by: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454 US License No. 2016 ©2019 Teva Pharmaceuticals USA, Inc. This Brief Summary is based on the full Prescribing Information for AJOVY AJO-002.

FRE-41620

March 2019

8/16/19 12:56 PM

6717

MINIIMIZE THE HASSLE OF ESR TESTING IN YOUR LAB

™

The miniiSED™ requires just 100µL of sample to provide fast, accurate and reliable ESR results in just 15 seconds!

ALCORSCIENTIFIC.COM

PRODUCTFOCUS

6718

LASER LIPO–NON-INVASIVE INSTANT INCH LOSS RESULTS From Laser Lipo Ltd

The FDA Approved, Strawberry Laser Lipo is a groundbreaking treatment offering non-invasive, instant inch loss results to the Abdomen, Hips, Thighs, Arms, Back Fat, Buttocks, Male Chest and Knees, without any pain or downtime. The clinically proven, non-invasive laser treatment penetrates the skin to selectively target the fat cells underneath, leaving blood vessels, nerves and other tissue undisturbed. Only $24,750 and 0% in-house no credit check financing.

View Brochures, Videos & Mores at POR.io Enter Number 6718 in the Search Area

www.PhysiciansOfficeNews.com 13 2019 Issue 8.indd 13

8/16/19 12:56 PM

FIRST EVER CLIA WAIVED HEMATOLOGY ANALYZER

PHYSICIANS office RESOURCE

2019 Issue 8

6719

From Sysmex

Faster test results, clinical decisions and greater practice efficiency are coming to physicians’ offices with the first CLIA-waived CBC analyzer. Hematology diagnostics leader Sysmex is bringing more lab testing to the point of care.

One of the most common blood tests can be conducted reliably and accurately on-site, in as few as three minutes.

The device’s ease of use and innovative technology means in-house staff can operate it in just a few easy steps, without lengthy certification and training. The new Sysmex XW100 will improve health care efficiency and patient care.

View Brochures, Videos & Mores at POR.io Enter Number 6719 in the Search Area

6720

COST-EFFECTIVE AI MEDICAL SCRIBE From Phraze

Are you frustrated with spending more time writing notes than seeing patients? Has the EHR become a “screen between” you and your patients? Are you interested in having a medical scribe, but find that the cost is prohibitive? Phraze’s is a cost-effective AI Medical Scribe software that analyzes the conversation between you and your patient. It then automatically produces a clinical note that is as beautiful as it is intelligent: saving you time and improving your connection to patients.

View Brochures, Videos & Mores at POR.io Enter Number 6720 in the Search Area

6721

BREWER’S FLEX™ ACCESS EXAM TABLE From Brewer

Step up to power table performance for less with Brewer’s Flex™ Access Exam Table. Industry-leading 700-lb. patient weight capacity, unique safety features and unmatched ergonomic patient access maximize your clinical efficiency and ROI. A streamlined footprint and optional upgrades like safety grab bars, stirrups, and pass-through work surface provide ultimate flexibility for your practice.

View Brochures, Videos & Mores at POR.io Enter Number 6721 in the Search Area

14

www.PhysiciansOfficeResource.com

2019 Issue 8.indd 14

8/16/19 12:56 PM

Is it Pain Management or Abuse of a Drug?

Take the guesswork out of your day by quickly and easily screening your patients using the automated Clinical Chemistry Syst em Chemistry System The Pentra C400 provides: • A comprehensive Drugs of Abuse menu, including: Creatinine, pH and Specific Gravity adulterant tests to ensure sample integrity • Fast and accurate results while you see the patient • Information to help implement specific pain management or drugs of abuse treatment plans • An easy to run format to meet your testing needs Consulting Services Available Do you need help setting up a Drugs of Abuse testing program at an affordable price? HORIBA Medical will connect you with industry-leading teams to help you get started.

A consultant will help you with the following: • Assist with the licensure application process, if required • Establish testing policies and procedures • Provide director-level oversight as needed • Support your business when you're up and running

6722

Pentra C400 Chemistry Analyzer

A compact benchtop analyzer to handle your drugs of abuse testing needs.

No special water/waste, electrical, or space requirements needed.

Contact your HORIBA Medical Representative for more information Explore the future 2019 Issue 8.indd 15

medical-marketing.us@horiba.com • (888) 280-1401 • www.horiba.com 8/16/19 12:56 PM

MICROS ES 60 HEMATOLOGY ANALYZER WITH 3-PART DIFFERENTIAL From HORIBA

PHYSICIANS office RESOURCE

2019 Issue 8

6723

Simple to use and easy to maintain with a zero maintenance concept, the Micros ES 60 is a small tabletop hematology analyzer with an integrated data management system. The analyzer provides a CBC with 3-part differential result in less than 60 seconds using only 10 µL of sample. Connect to the LiteDM Patient Data Management System for an affordable way to consolidate patient results to one report.

View Brochures, Videos & Mores at POR.io Enter Number 6723 in the Search Area

HISTOFREEZER® PORTABLE CRYOSURGICAL SYSTEM From OraSure - Histofreezer

6724

Histofreezer® Portable Cryosurgical System offers medical professionals an easy and effective method to treat nine different types of skin lesions, including common, plantar and genital warts and other common benign skin lesions. Medical professionals in primary care, internal medicine, podiatry, ob/gyn and dermatology areas of care have either added Histofreezer® to their practice offering or replaced more invasive and less tolerated procedures with Histofreezer®.

View Brochures, Videos & Mores at POR.io Enter Number 6724 in the Search Area

6725

FULLY AUTOMATED QUANTITIVE IMMUNOASSAY ANALYZER From Sekisui

The FastPack® IP System is a fully automated quantitative immunoassay analyzer designed for use in the Physician Office laboratory. Utilizing sophisticated chemiluminescence technology, the FastPack® IP System provides the capability to produce complex immunoassay results in 12 minutes or less with a push of a button. Menu includes Vitamin D, Testosterone, TSH, Free T4 PSA and hCG.

View Brochures, Videos & Mores at POR.io Enter Number 6725 in the Search Area 16

www.PhysiciansOfficeResource.com

2019 Issue 8.indd 16

8/16/19 12:56 PM

The Adview 2 is still the only truly modular diagnostic station that grows with your needs. Start with blood pressure and choose temperature or pulse oximetry option at the time of purchase.

Bionet CardioCare 2000: $1,255.00 Schiller AT-2 Plus: $2,275.00* *add Spirometry: $1,000.00 Burdick ELI 250c: $3,188.00 Welch Allyn CP150 w/ Interp: $3,258.00

6726

6727

6730

6728

6729

6731

6732 6733

6734

Coaxial Ophth, Fiber Optic Oto, Speucla Dispenser, Aneroid BP, Wall Transformer and Wall Board without Thermometer: $904.04 with Thermometer: $1,275.88

6735

6736

6737

6738

6739

2019 Issue 8.indd 17

8/16/19 12:56 PM

2019 Issue 8

PRODUCTFOCUS 6740

MEMORY LOSS BIOMARKERS TO AID IN DIAGNOSIS IN PRIMARY CARE PRACTICES

PHYSICIANS office RESOURCE

From Evoke Neuroscience

The eVox® System is an FDA 510(k) cleared medical device to aid primary and specialty care physicians in diagnosis of memory loss and other cognitive disorders. eVox® measures memory loss biomarkers that may aid in detecting memory loss sooner, identifying the root cause of memory loss, and performing a differential diagnosis. eVox® procedures are performed in-office and are reimbursable by Medicare and commercial payers.

View Brochures, Videos & Mores at POR.io Enter Number 6740 in the Search Area

6741

MAKE LABORATORY COMPLIANCE AND INSPECTION EASIER From My Inspection

Make laboratory compliance and inspections easier by changing how you document, save and retrieve all information necessary to meet CLIA and accreditation regulations. With two unique electronic tools My Compliance Manual and MyInspection™ Software, the guesswork and tedious task of interpreting and documenting policy, procedure, forms, charts and logs is over. Your lab will be compliant, have less paper, and be inspection ready.

View Brochures, Videos & Mores at POR.io Enter Number 6741 in the Search Area

PORTABLE, SINGLE CLICK OPERATION SPIROMETER From MicroDirect

6742

The MicroDirect SpiroUSB many features include single click operation of all main functions, full ATS/ERS test quality checks, real time Flow/Volume and Volume/Time traces, a choice of child incentive displays, choice of predicted values, estimated lung age, pre/post bronchodilator comparisons and can be used on multiple PC’s with dongle software protection key. The child incentive display and ATS quality checks ensure maximal results every time. Use with a laptop for true portability.

View Brochures, Videos & Mores at POR.io Enter Number 6742 in the Search Area 18

www.PhysiciansOfficeResource.com

2019 Issue 8.indd 18

8/16/19 12:56 PM

INTRODUCING THE NEW AFINIONâ&#x201E;˘ 2 ANALYZER

Simply more efficient.

6743

The Afinion 2 Analyzer provides POC A1C results in 3 minutes and ACR results in 5 minutes enabling face to face consultations and more timely treatment decisions.

TM

Highly accurate nn CLIA waived for A1C nn Quantitative results nn

No manual calibration required nn Ready to use controls nn

For more information or to request a demo on the Afinion 2 Analyzer please call 1-888-883-7692. abbott.com/poct Š 2019 Abbott. All Rights Reserved. All other trademarks referenced are trademarks of their respective owners. CVD187058 10004634 01/19

!25

2019 Issue 8.indd 19

8/16/19 12:56 PM

2019 Issue 8

PRODUCTFOCUS 6744

DEFINING MOBILE TELEDIAGNOSTICS

PHYSICIANS office RESOURCE

From MedPod

With the ability to deploy into a medical office in less than 2 minutes, MobileDoc is the ultimate portable practice. Revolutionary in its compact and mobile design, MobileDoc integrates best-in-class professional medical-grade devices with state-of-theart HD video and EHR connectivity. Physicians can provide care remotely that is on par or better than a face-to-face visit, including conducting basic exams, checking vitals, and performing specialty testing— shattering the boundaries of traditional care.

View Brochures, Videos & Mores at POR.io Enter Number 6744 in the Search Area

IDEAL SYSTEM FOR LOW-TO-MODERATE VOLUME LABORATORIES

6745

From Sekisui Diagnostics

The SK™500 chemistry instrument and SEKURE Reagents offer an ideal system for low-to-moderate volume laboratories seeking exceptional throughput with minimal use of space and water. The SK500 is a compact and efficient instrument with a full menu of reagents specifically designed for and packaged for the system

View Brochures, Videos & Mores at POR.io Enter Number 6745 in the Search Area

6746

PAD TESTING SYSTEMS IDEAL FOR PRIMARY CARE TO VASCULAR SPECIALISTS From Newman Medical

Your patients Trust You to find their PAD • You have many high risk patients, including anyone over 65 or diabetics or smokers • Even if they are unaware of their PAD, 25% will have a heart attack or stroke within 5 years if not managed • Patients often mistake symptoms of PAD for arthritis. simpleABI Cuff-Link systems are easy to learn and use • Push button remote, automatic calculations/waveforms • PC based – reports are easy to save and share Excellent Value and Reimbursements • One test per week pays off system in less than one year • Medicare reimbursements range from $80 to $220 depending on location and test

View Brochures, Videos & Mores at POR.io Enter Number 6746 in the Search Area 20

www.PhysiciansOfficeResource.com

2019 Issue 8.indd 20

8/16/19 12:56 PM

6749

6751

6755

6759

6763

2019 Issue 8.indd 21

6750

6748

6747

6752

6754

6753

6756

6760

6764

6758

6757

6761

6765

6762

6766

8/16/19 12:56 PM

2019 Issue 8

PHYSICIANS office RESOURCE

MOLECULAR LATERAL FLOW DIAGNOSTICS: A NEW ERA FOR POINT-OF-CARE TESTING Sekesui Diagnostics If you’re like many physicians and Point of Care (POC) laboratories, you may be dealing with suboptimal performance from some of your current diagnostic methods. For example, conventional Rapid Influenza Diagnostics Tests (RIDTs) vary in terms of sensitivity and specificity when compared with viral culture or reverse transcriptionpolymerase chain reaction (RT-PCR). Product insert information and research publications indicate that in general, RIDTs sensitivities are approximately 50-70%.

But the technology of point-of-care diagnostics is changing.

One particular evolving technology is molecular diagnostics, which detects specific sequences in DNA or RNA that may (or may not) be associated with disease. At present, there are molecular applications in infectious diseases, oncology, pharmacogenomics, genetic disease screening and coagulation, among others.

PCR: The Gold Standard, but Not Feasible in POC Polymerase chain reaction (PCR) has long been considered a diagnostic gold standard due to the high accuracy of the technology, which accounts for its use in core or reference labs.

It can detect disease with as few as several copies of a gene. But due to complicated workflows, complex procedures, cold chain storage, and time & economic costs, PCR hasn’t been feasible in a point-of-care setting.

PCR Now in the Palm of Your Hand Laboratories love the accuracy of results from molecular tests, though many still prefer the workflow of a traditional lateral flow test.

By combining top-performing PCR technology with stateof-the-art microfluidic testing – and merging it into a POC-

friendly workflow – physician office labs finally get cutting-edge molecular lateral flow systems with the best of both worlds: PCR-quality results and the ease of use of conventional lateral flow rapid diagnostics.

For physicians, this provides the convenience and procedural familiarity of traditional POC rapid immunoassays - while providing the superior sensitivity, specificity and information provided by laboratory-based PCR testing.

Advantages of Molecular Lateral Flow Technology Compared to other methods, molecular lateral flow technology has significant point-of-care advantages: • Laboratory PCR performance.

• No cold chain storage – the test and its components can be stored in ambient environments.

• Easy to use – each test needs less than 2 minutes of handson time.

• Affordability – with a single test diagnosis, reducing send out lab costs for confirmatory testing.

• State-of-the-art microfluidic cassette technology with a compact portable Dock allows for true molecular PCR testing to be performed anywhere testing is needed.

Since the U.S. FDA reclassified antigen-based Rapid Influenza Diagnostic Tests (RIDTs) requiring increased sensitivity, specificity and annual strain testing quality controls for RIDTs, the value of molecular testing has become more widely recognized. With the Silaris Influenza A&B Test, hospitals and physician office laboratories can step up to molecular testing and benefit from a simplified workflow and greater performance for early detection & proper management of influenza.

22 www.PhysiciansOfficeResource.com 2019 Issue 8.indd 22

8/16/19 12:56 PM

Molecular testing in the palm ofyour hand.

SILARIS® FLU A&B AND RSV TESTS True molecular PCR technology in a rapid lateral flow format at the point-of-care. ®

For information please visit us at silaris.com

6767

537, 616-0 ore 8 8 8 Call n 2, for m Optio ormation inf

For In Vitro Diagnostic Use Only © 2019 Sekisui Diagnostics, LLC. All rights reserved. Silaris® is a registered trademark ofSekisui Diagnostics, LLC. Because every result matters™ is a trademark ofSekisui Diagnostics, LLC.

2019 Issue 8.indd 23

8/16/19 12:57 PM

6768

DRUGS OF ABUSE TESTING AND ROUTINE CHEMISTRY PANELS ON A SINGLE ANALYZER From Carolina Liquid Chemistries

PHYSICIANS office RESOURCE

2019 Issue 8

PRODUCTFOCUS

Carolina Liquid Chemistries Corp. announces the successful launch of Medica Corporation’s high-speed benchtop analyzer, the EasyRA®. The updated analyzer now operates at a photometric rate of up to 240 tests per hour or up to 480 tests per hour with ISE. The EasyRA urine drug screening and general chemistry reagents are CLIA categorized as moderately complex. This all-in-one system allows clinical laboratories to screen for drugs of abuse in urine while also allowing healthcare providers to assess routine chemistry panels on a single analyzer.

View Brochures, Videos & Mores at POR.io Enter Number 6768 in the Search Area

6769

THE BREWER CENTURY SERIES STOOL From Brewer

Has a pneumatic height adjustment, 16” wide, 4” thick poly-foam seat cushion, and five-leg 23” brushed aluminum accent base. Optional adjustable 18” chrome footing. Optional adjustable contoured backrest with black plastic shroud.

View Brochures, Videos & Mores at POR.io Enter Number 6769 in the Search Area

6770

ACCURATE, ACTIONABLE RESULTS FROM THE LEADER IN POINT-OF-CARE LIPID TESTING From Abbott

The CLIA-waived Alere Cholestech LDX™ Analyzer is engineered for confidence, providing accurate, actionable, and readily accessible results that have set the standard in point-of-care lipid profile, cholesterol, and glucose testing. Results are easy to obtain.

Fingerstick sampling and a small sample size (40μL) makes results less painful and time consuming.

View Brochures, Videos & Mores at POR.io Enter Number 6770 in the Search Area

24

www.PhysiciansOfficeResource.com

2019 Issue 8.indd 24

8/16/19 12:57 PM

MDescapes

FOUR SEASONS ANGUILLA

Sun-seeking vacationers eager to learn more about Caribbean island culture while unwinding on the property’s luxurious white sand beaches and tranquil blue waters will find plenty of reason to celebrate on Anguilla this summer.

The Experience Anguilla package provides extra value with a fifth night free plus all the following:

Complimentary daily breakfast in Coba for 2 (per bedroom) Complimentary Kids For All Seasons activities Children under 12 eat free with each paying adult Rates starting at USD 550 for a Resort View

Additional Details at MyMDescapes.com

June 2019

• • • •

FOUR SEASONS ORLANDO Within the gates of Walt Disney World ® Resort, discover Central Florida’s only resort to receive the coveted AAA Five Diamond Award. A perfect blend of Four Seasons experiences and Disney offerings––for family time, for romance, or special events. Create a Four Seasons-only getaway in Orlando, with golf, spa, dining and a fun-filled island for kids, or make the Resort your base for a Disney adventure. No one brings dreams to life quite like Four Seasons and the magic of Disney.

Additional Details at MyMDescapes.com

$50 Daily Resort Activities Credit!

FOUR SEASONS COSTA RICA Nestled on a Pacific coast hillside and overlooking golden sand beaches, Four Seasons Resort Costa Rica at Peninsula Papagayo is your premier eco-adventure destination. This year, join us to experience Costa Rica’s renowned “pura vida” lifestyle and our exciting renovation. The Resort’s 181 guest rooms, suites and residences capture the exotic character of Costa Rica, with comfortable rattan and bamboo furnishings, local artwork and indigenous wood and stone finishes.

Additional Details at MyMDescapes.com

Reserve 5 Nights in Luxurious Accommodations and Receive 2 Additional Nights On Us!

FOUR SEASONS PUNTA MITA Sunshine and perfect temperatures year round, a secret landscape of astonishing beauty and the Pacific Coast’s most scenic beach. This and much more awaits you at Four Seasons Resort Punta Mita. With 173 rooms including 32 suites (all suites with private plunge pools), an option for everybody is available. In addition, Four Seasons private 4 and 5 bedroom Villas offer the true home away from home experience.

Additional Details at MyMDescapes.com

Receive a Third Night in Luxurious Accommodations FREE with Every Two Consecutive Paid Nights!

2019 Issue 8.indd 25

All offers on this page are subject to availability at the time of reservation. Limited Time Only. Offers may not be combined with any other promotions/program benefits/offers/savings. Subject to change without notice.

8/16/19 12:57 PM

2019 Issue 8

PRODUCTFOCUS 6771

FIRE YOUR FINANCIAL ADVISOR

PHYSICIANS office RESOURCE

From White Coat Investor

Fire Your Financial Advisor is the course that should’ve been taught to you in college, medical school, or residency but never was. For 1/10th the price and half the time of hiring a professional financial planner, this course will take you from feeling anxious and having no plan to having a written financial plan you can follow the rest of your investing career as a professional and a retiree. Topics covered include insurance, investing, retirement planning, and much more. Learn more at whitecoatinvestor.com.

View Brochures, Videos & Mores at POR.io Enter Number 6771 in the Search Area

6772

MICROS HEMATOLOGY ANALYZER WITH 3-PART DIFFERENTIAL PLUS THE LITEDM From HORIBA

Is it viral or bacterial? A CBC with 3-part differential can provide the clues to help distinguish between viral and bacterial infections before you decide to treat.

The Micros 60 Hematology analyzer provides a CBC with 3-part Diff result in less than 60 seconds using only 10 µL of sample. Connect to the LiteDM Patient Data Management System for an affordable way to consolidate patient results to one report.

View Brochures, Videos & Mores at POR.io Enter Number 6772 in the Search Area

6773

CLIA-WAIVED COMPREHENSIVE METABOLIC PANEL From Abbott Point of Care

The Piccolo Xpress™ point-of-care chemistry analyzer delivers comprehensive CLIA waived diagnostics to Physician Offices. In 3 easy steps, the Piccolo provides lab-accurate results in minutes from a menu of 29 general chemistry tests, including lipids, liver, kidney, metabolic and other specialty functions. By using only 100 microliters of whole blood, serum or plasma - physicians can make confident treatment decisions faster, thereby increasing the efficiency, throughput and capacity of their practice, while also increasing revenue and ensuring patient satisfaction.

View Brochures, Videos & Mores at POR.io Enter Number 6773 in the Search Area

26

www.PhysiciansOfficeResource.com

2019 Issue 8.indd 26

8/16/19 12:57 PM

YOU BELONG AT FOUR SEASONS ANGUILLA OWNERSHIP AS EASY AS THE ISLAND ITSELF Here on the welcoming island of Anguilla, the turquoise water and azure blue sky meet in harmonious accord. You anticipate the peace of Anguilla before you ever get on the plane, and upon arrival your remaining cares simply roll away with the Caribbean tide. World-renowned Four Seasons service and carefree luxury are yours to enjoy. We welcome you home. You belong.

DELUXE STUDIOS TO 5 BEDROOM VILLAS FROM $825,000 TO OVER $10 MILLION TO FIND OUT MORE OR PLAN A DISCOVERY WEEKEND, CALL +1 800 901 7079 OR EMAIL US AT INFO@ANGUILLAPRIVATERESIDENCES.COM

AnguillaPrivateResidences.com

This offer is not directed to residents in any state in which a registration is required but in which registration requirements have not yet been met, including, but not limited to, New Jersey. Recreational features and amenities described herein are subject to change periodically. Warning: the California Department of Real Estate has not examined this offering, including, but not limited to, the condition of title, the status of blanket liens on the project (if any), arrangements to assure project completion, escrow practices, control over project management, racially discriminatory practices (if any), terms, conditions, and price of the offer, control over annual assessments (if any), or the availability of water, services, utilities, or improvements. It may be advisable for you to consult an attorney or other knowledgeable professional who is familiar with real estate and a law in the country where this subdivision is situated. In New York, the complete offering terms are in an offering plan available from sponsor.

File no. CD11-1029 (Resort Residences) and fi le no. H11-0007 (Villas).

Four Seasons Private Residences Anguilla are not owned, developed or sold by Four Seasons Hotels limited or its affi liates (Four Seasons). The developer, an affi liate of Starwood Capital Group, uses the Four Seasons trademarks and tradenames under a license from Four Seasons Hotels limited.

The marks “FOUR SEASONS,” “FOUR SEASONS HOTELS AND RESORTS,” any combination thereof and the Tree Design are registered trademarks of Four Seasons Hotels Limited in Canada and U.S.A. and of Four Seasons Hotels (Barbados) Ltd. elsewhere. © 2019

2019 Issue 8.indd 27

8/16/19 12:57 PM

2019 Issue 8

PRODUCTFOCUS

PHYSICIANS office RESOURCE

6774

THE BREWER BASIC EXAM TABLE From Brewer

Full featured, entry-level exam table design. The Brewer Basic Exam Table features a pneumatic cylinder, seamless upholstery, and the largest storage capacity available. We invite you to compare features, price, warranty and you will find the Brewer Basic Exam Table is clearly the best entry level exam table available.

View Brochures, Videos & Mores at POR.io Enter Number 6774 in the Search Area

6775

OPTIMIZE PRODUCTIVITY AND EXPAND YOUR PRACTICE From MedPod

The Medpod Medical Cart optimizes productivity and load balancing by enabling access to remote physicians during high volume periods or to reach low-density populations. Medpod’s proprietary software integrates with a wide range of professional medical devices and gives the remote provider control of the devices to conduct an examination that is on par with a face-to-face visit. Patient images, audio and data can be captured, annotated, tagged and uploaded in real-time or stored and forwarded into the EHR by either remote or local provider.

View Brochures, Videos & Mores at POR.io Enter Number 6775 in the Search Area

6776

ULTRA HCG COMBO TEST From Sekisui Diagnostics

The OSOM® Ultra hCG Combo test is a simple immunoassay for the qualitative detection of human chorionic gonadotropin (hCG) in serum or urine for the early confirmation of pregnancy. Internal studies have confirmed that the OSOM® Ultra hCG Combo test does not have a false negative result from hCG variants providing physicians with a higher level of confidence.

View Brochures, Videos & Mores at POR.io Enter Number 6776 in the Search Area

28

www.PhysiciansOfficeResource.com

2019 Issue 8.indd 28

8/16/19 12:57 PM

6778

6777

#5316

Call 888-522-9939 or Visit medpod.por.io for More Information

2019 Issue 8.indd 29

8/16/19 12:57 PM

6779

THE RX DAYTONA+ From Randox

A bench-top, fully automated, random-access chemistry analyzer, providing routine and specialized testing with emergency STAT sampling functionality.

Demonstrating unparalleled versatility, the RX daytona+ combines robust hardware and intuitive software with the world-class RX series test menu, including specific proteins, lipids, therapeutic drugs, drugs of abuse, antioxidants and diabetes testing. The RX daytona+ ensures unrivalled precision, reliability and accuracy for results you can trust.

PHYSICIANS office RESOURCE

2019 Issue 8

PRODUCTFOCUS

View Brochures, Videos & Mores at POR.io Enter Number 6779 in the Search Area

PENTRA XLR HEMATOLOGY ANALYZER WITH 5-PART DIFFERENTIAL

6780

From HORIBA Medical

The Pentra XLR hematology analyzer with autoloader provides a CBC with 5-part Diff result using proprietary technology that ensures an accurate count and differential on the first run. The Pentra XLR also provides a complete menu of Retic parameters for treating oncology and anemia patients. The autoloader processes 80 samples an hour and provides random continuous access for mediumto high-volume clinics and rural or community hospitals.

View Brochures, Videos & Mores at POR.io Enter Number 6780 in the Search Area

6781

LAB-ACCURATE RESULTS FOR ACR AND HBA1C From Abbott

With its compact size and panel of tests, the Afinion 2 system is ideal for point-of-care testing in physician offices, clinics, community health centers and hospital out-patient clinics. From just a small urine or fingerstick whole blood sample, lab-accurate results for ACR and HbA1c are made available during the consultation.

View Brochures, Videos & Mores at POR.io Enter Number 6781 in the Search Area

30

www.PhysiciansOfficeResource.com

2019 Issue 8.indd 30

8/16/19 12:57 PM

6782

6783

6784

6785

6786

2019 Issue 8.indd 31

8/16/19 12:57 PM

6787

TURN SMALL PLACES INTO SMART SPACES From Abbott

With reduced budgets, shrinking laboratory space and staffing challenges, many laboratories need a solution that lets them work smarter with less. The CELL-DYN Emerald 22 AL is a full performance, automated optical 5-part differential analyzer that delivers smarter results for small to midsize clinical laboratories.

• Compact Design • Walkaway Functionality • Ease Of Use • Smart Safety Features

PHYSICIANS office RESOURCE

2019 Issue 8

PRODUCTFOCUS

View Brochures, Videos & Mores at POR.io Enter Number 6787 in the Search Area

6788

SINGLE, INTEGRATED POC TESTING SOLUTION From Abbott Point of Care

The fully automated i-STAT System offers a broad menu of tests for diagnostic and treatment indicators related to disease state management and clinical practice guidelines.

Using just 2 or 3 drops of blood, the system provides timesensitive tests at the patient’s side in just minutes.

View Brochures, Videos & Mores at POR.io Enter Number 6788 in the Search Area

6789

PENTRA 60 C+ HEMATOLOGY ANALYZER WITH 5-PART DIFFERENTIAL From HORIBA

Now you can have the same results hospitals and reference labs provide in a small, benchtop analyzer. The Pentra 60 C+ hematology analyzer provides a CBC with 5-part differential result using proprietary technology that ensures an accurate count and differential on the first run.

Reduce repeats and reflex to the microscope with Pentra hematology technology.

View Brochures, Videos & Mores at POR.io Enter Number 6789 in the Search Area

32

www.PhysiciansOfficeResource.com

2019 Issue 8.indd 32

8/16/19 12:57 PM

It's flu season.

Which test are you using?

Simplify workflow, results and patient management.

The CLIA-Waived BD Veritor™ Plus System for Rapid Detection of Flu A+B simplifies workflow and provides clear and quick results for appropriate patient management within the same visit.

• One button functionality, easy to use and implement • Unambiguous digital flu result in under 11 minutes* • Demonstrated performance compared to molecular tests1 • Low cost of ownership

Simply the right POC test for influenza, Group A Strep and RSV.†

6790

Request a demo today at go.bd.com/VeritorPOR *Results after 10-minute incubation period for Flu A+B and RSV; after 5-minute incubation period for Group A Strep † RSV- Respiratory Syncytial Virus References: 1. BD Veritor System for Rapid Detection of Flu A+B, CLIA-waived kit package insert, 8087667 (14) 2018-06.

BD Veritor System for Rapid Detection of Flu A+B, laboratory kit package insert, 8087666 (11) 2017-10.

BD, 7 Loveton Circle, Sparks, MD 21152-0999 USA Tel: 1.888.211.6980 1.800.638.8663 © 2018 BD. BD, the BD Logo and all other trademarks are property of Becton, Dickinson and Company.

40 2019 Issue 8.indd 33 BDVeritor_ad_PhysicianOfficeResource.indd 1

www.PhysiciansOfficeResource.com 8/16/19 12:57 PM 11/5/18 1:17 PM

6791

ACCUTEST PH® PHENAPHTHAZINE PAPER From Jant Pharmacal

PHYSICIANS office RESOURCE

2019 Issue 8

PRODUCTFOCUS

Test papers give instant, easy-to-read results, with clear, bright matches at 0.5 intervals from pH 4.5 to 7.5. Color charts are lab-tested for precision accuracy.

Made in the U.S.A. with state-of-the-art materials.

An FDA-listed medical test product, used in hospitals and doctor’s offices around the world. Economical – approximately 100 tests/roll. Widely used in hospitals and doctors’ offices to detect the presence of amniotic fluid in vaginal secretions during late-term pregnancy, a sign of premature amniotic sac rupture.

View Brochures, Videos & Mores at POR.io Enter Number 6791 in the Search Area

6792

PENTRA C400 CHEMISTRY ANALYZER From HORIBA Medical

One benchtop, not a whole lab! No water system, drain or special electrical connected required to operate the Pentra C400 chemistry analyzer. Now you can have the power of a floor model analyzer on the benchtop! The Pentra C400 chemistry system processes up to 420 tests/hr including ISEs and offers routine metabolic assays, TDMs, DAUs and Adulterants, HbA1c and Vitamin D tests. With 40 open channels, you can add much more for a complete menu to meet your practice needs.

View Brochures, Videos & Mores at POR.io Enter Number 6792 in the Search Area

SPOTCHEM™ EZ CHEMISTRY ANALYZER 6793

From Jant Pharmacal

SPOTCHEM™ EZ chemistry analyzer is a small bench top chemistry analyzer that utilizes dry chemistry technology to test whole blood. Results are available on the SPOTCHEM™ printer or downloaded via LIS. SPOTCHEM™ is ideally suited for small laboratories and physician offices that desire an easy-to-use analyzer with a small footprint. Maximum throughput is 48 tests per hour.

Test menu includes 21 tests and 3 panels. Tests whole blood, serum or plasma with rapid results within 4 – 15 minutes. Extensive CLIA-waived menu, includes lipid panel, creatinine, AST, ALT, glucose, and 2 chemistry panels. Automatic calibration.

View Brochures, Videos & Mores at POR.io Enter Number 6793 in the Search Area 34

www.PhysiciansOfficeResource.com

2019 Issue 8.indd 34

8/16/19 12:57 PM

Win a FREE iPad Mini!

Join POR as we conduct our first in a series of brief surveys, designed to give a voice to providers. With your help we can better understand what’s trending in physician offices, laboratories, and healthcare facilities across America, and help improve office and laboratory proficiency, profitability, and patient care.

As a Thank You, we’ll report the results from this and future surveys in Physicians Office Resource magazine. Moreover, we will enter you in our periodic drawing for a FREE Apple iPad, which you may gift to someone or keep for yourself.

The more surveys completed, and the more questions you answer in each, the more chances you will have to win.

www.survey.por.io 2019 Issue 8.indd 35

8/16/19 12:57 PM

2019 Issue 8

PHYSICIANS office RESOURCE

GIVE YOUR PRACTICE THE RECOGNITION IT DESERVES –ADVERTISE Chris Panebianco, Chief Marketing Officer for Bankers Healthcare Group (BHG), the leading provider of financial solutions for healthcare professionals.

To attract new patients, you have to get the word out about your practice. You can do this through conducting a marketing campaign or by testing the waters with a simple print advertisement in your local newspaper. Buying an ad is a big investment, so be smart and ask the right questions before signing any contract.

According to Medical Economics, less than 50% of patients stay with the same practice for more than five years. Marketing today is a necessity for standing out from the competition, building awareness of your practice, and retaining and gaining patients. Placing an ad is a good way for some doctors to test the water in their markets— especially when there is ripe opportunity to attract the 50% of patients looking for a new provider.

I’m willing to bet your practice has an online presence via Facebook. If you aren’t using Facebook consider this — according to its website, as of March 31, 2017, there were 1.97 billion active users. With over a quarter of the world’s population on Facebook, the market is simply too big to ignore.

Staying active on your Facebook page is only half the battle, though. According to social media research firm Locowise for company pages with fewer than 1,000 likes, only 23% of organic content reaches page followers. In other words, less than a fraction of the page’s followers ever even see a post. That’s a huge missed opportunity! The only way to get more eyeballs on your content is to pay to get it seen, either by “boosting” a post or buying an ad.

My 15 years in marketing have given me firsthand experience to see what works and what doesn’t in advertising. Ads can be expensive or they can be cheap.

36

What really matters is if you’re getting a good return on investment. Here are some questions to ask yourself before you get started.

1. What’s my Goal?

First, decide what you want your ad to do. Are you trying to bring in new patients or sell a new service? Then decide how you’re going to measure achieving your goal so you can determine if the investment was worth it. For example, “Increase new patient applications in July and August” or “Double the number of attendees at healthy eating seminar.” Create your goals so they can be measured with concrete numbers and be sure they align with the long-term goals of your practice.

2. What’s my budget?

Next, decide what you’re willing to spend. Depending on the medium—TV, radio, print, Facebook—the cost and payment structure will vary. The amount you want to spend may help you narrow down the right medium. For example, it’s significantly cheaper and more scalable to run a Facebook ad campaign compared to producing and running a TV commercial in your market.

A common industry strategy for budgeting is setting a patient acquisition cost (PAC). Ask yourself how much you’re willing to spend to bring one new patient to your practice and apply that number to your goal.

If you value acquiring a new patient at $25 and your goal is to bring in 100 new patients, set your budget to $2,500. And don’t forget to put a value on your time! Again, depending on the medium, the required time and resources will vary, so be sure to factor in how much time and

www.PhysiciansOfficeResource.com

2019 Issue 8.indd 36

8/16/19 12:57 PM

additional cost to produce your ad will be required.

5. How can I tell it worked?

3. What do I want to say?

This is where your measureable goals come in — between An advertisement is a sales pitch, so you want to get your tracking and research, it shouldn’t be too difficult to message across as quickly and effectively as possible. calculate your return on investment.

Your key message should help set you apart from the Online advertising can do the work for you, giving you competition. Do you offer a unique service or product, data on the amount of clicks you’ve received and number or have expert certifications of people you’ve or awards? Are you running directed to your “Ads can be expensive or they can be a promotional special for website. cheap. What really matters is if you’re discounted services? These are Other forms getting a good return on investment. elements that can be leveraged of advertising Here are some questions to ask yourself into your message to help you can be measured before you get started: reach your goals. through simple 1. What’s my goal?

Research different mediums survey research.

2. What’s my budget?

3. What do I want to say? to hit different target audiences Ask patients where 4. Have I done my legal homework? and demographics. You’re they heard of your 5. How can I tell it worked? going to have different people practice via email, 6. What are my next steps?” seeing your Facebook ads than offer an incentive your newspaper ads, so your if they mention Chris Panebianco message and tone may have to your ad or simply be adjusted accordingly to best compare sales before resonate. and after.

4. Have I done my legal homework?

6. What are my next steps?

Advertising is already regulated at both state and national Refine and re-launch. Take what worked over the course of levels; pay close attention to what you say and how you your previous ad and further refine it for the future. say it. Avoid anything that may come off as deceptive, Successful advertising will take some risk and misleading or embellished. experimentation – don’t be afraid to try out new messages Be prepared to backup any claim you make with or explore new mediums, they can help you reach the right concrete proof, especially when referring to anyone in your audiences and achieve your goals. practice as an expert, specialist, etc.

Advertising your practice isn’t as big of a headache as For further counsel on the legal implications that come you may think it can be. When done correctly, advertising with healthcare advertising, many professional associations can be both an effective and affordable investment for can offer guidelines and assistance. future revenue and opportunities.

Read this and other articles at www.PhysiciansOfficeNews.com 2019 Issue 8.indd 37

37

8/16/19 12:57 PM

6794

SELF-CONTAINED DIAGNOSTIC WORKSTATION From Vitalograph

Vitalograph introduces the Compact Expert diagnostic workstation. The device is a full touch-screen based medical workstation, which comes equipped with Vitalograph’s flagship Pneumotrac spirometer. This accurate, robust and linear Fleisch pneumotach produces over 50 spirometry parameters, automatically stores all test data, calibration data and clinical audit trail data in a secure network capable SQL Server database.

An intuitive user interface enhances the routine workflow in most practices, allowing quick patient throughput. Beyond spirometry, it is a desktop testing station for ECG, Pulse Oximetry, Weight , COPD assessment, and Blood Pressure measurements.

PHYSICIANS office RESOURCE

2019 Issue 8

PRODUCTFOCUS

View Brochures, Videos & Mores at POR.io Enter Number 6794 in the Search Area

6795

“ mInIIMIZE THE HASSLE OF ESR TESTING IN YOUR LAB

From ALCOR

miniiSED™ is the newest of the iSED® family of ESR analyzers from ALCOR Scientific. The miniiSED™ measurement of ESR is accurate and unaffected by variables associated with traditional methodologies, such as hematocrit. This single position, fully automated ESR analyzer works directly from primary EDTA tubes, requires 100 μL of sample, has an internal barcode reader, and produces results in 15 seconds! miniiSED™ is the ideal solution to ESR testing for small laboratories, POL’s, and emergency clinics. Proudly manufactured in the USA.

View Brochures, Videos & Mores at POR.io Enter Number 6795 in the Search Area

6796

THE RX IMOLA From Randox

A fully automated, random access analyzer with STAT sampling functionality; boosting productivity and saving time when it matters most. Developed for medium-high throughput laboratories, the RX imola provides comprehensive testing with the world-class RX series test menu, including specific proteins, lipids, therapeutic drugs, drugs of abuse, antioxidants and diabetes testing. The RX imola: A cost-effective system that delivers consistent high quality results with a small footprint.

View Brochures, Videos & Mores at POR.io Enter Number 6796 in the Search Area 38

www.PhysiciansOfficeResource.com

2019 Issue 8.indd 38

8/16/19 12:57 PM

A better way.

They’re Here Flu, RSV, Strep. Be Ready.

With confirmatory molecular results,

Cepheid’s CLIA Waived test menu delivers peace of mind to you and your patients.

6797

6798

6799

Xpert Xpress Flu/RSV

Xpert Xpress Flu

Xpert Xpress Strep A

• One sample. One Cartridge.

Three results

• Qualitative, molecular detection and differentiation of influenza A and B

• Accurate, real-time PCR molecular testing for Group A Strep

• Qualitative, molecular detection and differentiation of influenza A, influenza B and RSV

• Sample types include nasal swab and nasopharyngeal swab

• Internal QC in each cartridge

®

®

• Room Temperature reagent storage

®

• No confirmation required for negative results*

• Sample types include Nasal swab and Nasopharyngeal swab

For more information, call (888) 256-6990 For in vitro diagnostic use. * No culture confirmation required for negative results unless clinical symptoms persist, or there is an outbreak of acute rheumatic fever (ARF).

904 Caribbean Drive | Sunnyvale, CA 94089 USA | TOLL FREE +1.888.336.2743 | PHONE +1.408.541.4191 | FAX +1.408.541.4192 | www.cepheid.com

2019 Issue 8.indd 39

8/16/19 12:57 PM

Get more of the story, faster.

Improve patient flow with on-site, syndromic gastrointestinal disease testing from BioFire.

Waiting hours or days for laboratory results for gastroenteritis can make patient management decisions complicated. The BioFireÂŽ FilmArrayÂŽ Gastrointestinal (GI) Panel simultaneously tests for 22 of the most commonly associated pathogens related to gastroenteritis. And now, tests can be performed right in the office.*

6800

Faster Diagnosis. Better Patient Care.

Shorten Time to Results With results in about one hour, you can diagnose patients faster and possibly reduce further medical follow-up.

Improve Operational Efficiency The BioFire GI Panel is easy-to-use, it takes just two minutes of hands-on time and 0.2 mL sample in Cary Blair.

Prescribe the Right Treatment Improve your Antimicrobial Stewardship Program by aiding in more accurate and timely diagnosis and potentially reducing unnecessary antibiotic prescriptions.

biofiredx.com

*CLIA moderate complexity certification is required

2019 Issue 8.indd 40

BFR0000-2962-01

8/16/19 12:57 PM